IL10 rs1800890: Understanding the Promoter Variant
The rs1800890 variant is a single nucleotide polymorphism located in the promoter region of the IL10 gene. It is studied for its potential role in influencing the production levels of the anti-inflammatory cytokine IL-10 and its association with various immune-related conditions.
What each genotype means
Potential immune response variation
This genotype has been studied for its potential role in modulating immune responses and susceptibility to certain conditions. Some research suggests that individuals with this genotype may have different risks for specific health outcomes, such as non-Hodgkin lymphoma when combined with certain environmental exposures, though evidence remains limited and complex. Please discuss any concerns regarding your immune health or specific disease risks with a qualified healthcare provider.
This genotype is common, with the minor allele frequency for this variant typically ranging between 0.30 and 0.40 across major global populations.
Typical immune response variation
Carrying one copy of each allele is a common genetic profile that may influence the regulation of IL-10 cytokine production. Research into this variant often focuses on how it interacts with other factors to affect immune function, but the clinical significance for an individual is not well-defined. This information should not be used for medical diagnosis; consult with a clinician to understand how your genetic background relates to your overall health.
As a heterozygous genotype, this is frequently observed in populations where both the A and T alleles are prevalent.
Potential immune response variation
This genotype is associated with variations in the IL-10 promoter region, which may influence the levels of anti-inflammatory cytokines produced by your immune system. While some studies have linked this variant to differences in lung function or immune-related conditions, the evidence is not conclusive and varies by context. Always speak with a healthcare professional to interpret these findings in the context of your personal medical history.
This genotype is found in a significant portion of the population, consistent with the reported minor allele frequencies for this variant.
What is the rs1800890 Variant?
The rs1800890 variant is a specific change in the DNA sequence within the IL10 gene, which encodes interleukin-10. This variant is located in the distal promoter region of the gene, specifically identified as the -3575T/A polymorphism. In genetics, a promoter region acts as a control switch, determining how much of a protein is produced by the cell. Because rs1800890 sits in this regulatory area, researchers investigate whether the presence of a T or an A allele alters the efficiency of the IL-10 gene's expression. By studying this site, scientists aim to understand how subtle variations in our genetic code might lead to differences in how our immune systems respond to environmental triggers or medical interventions.
The Role of the IL10 Gene
The IL10 gene provides instructions for making interleukin-10, a critical cytokine that functions as an essential immunoregulator. Cytokines are signaling proteins that help cells communicate during an immune response. Interleukin-10 is primarily known for its anti-inflammatory properties; it helps to dampen the immune system, preventing excessive inflammation that could damage healthy tissues. By maintaining this balance, IL-10 plays a vital role in protecting the intestinal tract and managing the body's response to infections and autoimmune challenges. Because of its central role in immune homeostasis, variations in the IL10 gene, such as those in the promoter region, are frequently examined to see if they correlate with differences in cytokine output, which may influence an individual's susceptibility to inflammatory or immune-mediated conditions.
Research Associations and Evidence Strength
Research into rs1800890 has explored its association with various health traits, though the evidence remains limited and often context-dependent. Some studies have linked the A-allele to lower levels of IL-10 production, which could theoretically impact how the body manages inflammation. In clinical research, this variant has been investigated for its potential association with susceptibility to graft-versus-host disease, as well as risks for certain types of non-Hodgkin's lymphoma and idiopathic thrombocytopenic purpura. However, it is important to note that these findings are often based on specific populations or small study cohorts. Many of these associations have not been consistently replicated across diverse ethnic groups, meaning the clinical significance of this variant is not yet fully established. Current evidence suggests that while the variant may influence biological pathways, it is likely one of many factors contributing to complex health outcomes.
Understanding Your Results
If you have received information about your rs1800890 genotype, it is important to view this data as a small piece of a much larger biological puzzle. Genetic variants like rs1800890 do not act in isolation; they interact with other genes, environmental factors, and lifestyle choices to shape your health. Because the evidence linking this specific SNP to clinical outcomes is limited and often mixed, it cannot be used to predict a specific health outcome or diagnose a condition. You should never use this information to make medical decisions, such as starting or stopping medications or changing your diet. If you have concerns about your immune health or specific medical conditions, the most appropriate step is to consult with a qualified healthcare provider or a genetic counselor who can interpret your results within the context of your overall medical history.
How common is this variant?
The minor allele frequency for rs1800890 is approximately 0.30 to 0.40 across major world populations, making it a relatively common variant.
Frequently asked questions
Is rs1800890 a diagnostic test for disease?
No, rs1800890 is not a diagnostic test. It is a common genetic variant that has been studied for its potential influence on immune function, but it is not used to diagnose any specific medical condition.
Does having the A allele mean I have low IL-10?
Some experimental research suggests an association between the A allele and lower IL-10 production, but this is not a direct measurement of your personal cytokine levels. Many factors, including your overall genetic background and environment, determine how much IL-10 your body produces.
Should I be worried about my rs1800890 result?
There is no reason for concern based on this variant alone. It is a common genetic variation found in a large portion of the population, and its clinical impact is not well-defined or considered a primary driver of disease.
Can I change my gene expression for IL10?
You cannot change your DNA sequence. While you can influence your overall health through lifestyle choices like diet, exercise, and stress management, these do not alter the underlying genetic variant at the rs1800890 site.
Sources & further reading
Educational information only, last refreshed 9/21/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1800890?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in IL10
Regulatory upstream noncoding variant in IL10 that influences anti-inflammatory cytokine production.
The IL-10 promoter -819C/T polymorphism modulates interleukin-10 expression, influencing inflammatory responses and autoimmune susceptibility.
The -592C/A variant in the promoter of IL-10 regulates transcription factor binding, impacting cytokine output and risk for inflammatory bowel disease.
Functional promoter variant (-1082 A/G) influencing interleukin-10 expression levels and inflammatory disease susceptibility.
Functional regulatory promoter variant in IL10 associated with altered interleukin-10 expression and enhanced susceptibility to dust mite allergic sensitization.
Variant in the interleukin-10 gene interacting with environmental dust mite exposure to significantly alter the risk of allergic sensitization and exacerbations.